Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
Athiththan Yogeswaran(Justus-Liebig-Universität Gießen), Henning Gall(German Center for Lung Research), Tim Oqueka(University Medical Center Hamburg-Eppendorf), Jonas Lund(Justus-Liebig-Universität Gießen), Jan K. Hennigs(Universität Hamburg), Natascha Sommer(Cardio-Pulmonary Institute), Lars Harbaum(Universität Hamburg), Hans Klose(University Medical Center Hamburg-Eppendorf), Khodr Tello(Universities of Giessen and Marburg Lung Center), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Manuel J. Richter(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Werner Seeger(Universities of Giessen and Marburg Lung Center)
Cited by 28
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
|Journal of the American College of Cardiology|2006|612
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
|Nature Communications|2018|382